The industry standard technology Enzyme-Linked Immuno-Sorbent Assay (ELISA) is widely used in biology and medicine for detection of viruses, bacteria, cancer markers, and other physiologically active substances.
ALLIS is developing a Flow-Through Counting Assay (FTCA) which has the potential to meet WHO criteria for point of care tests and has several advantages over other manual rapid tests under development and on the market.
Ultrasound-enhanced Particle Agglutination (UPA) is a platform technology in which ultrasound is used to improve the performance of conventional particle agglutination immunoassays.
Welcome To Allied Innovative Systems
Allied Innovative Systems (ALLIS) is a Research and Development company, which develops new technologies for the healthcare and consumer markets. ALLIS supported in part by the NIH Small Business Innovation Research (SBIR) grants
With the support of NIH grants, ALLIS has developed several novel technologies in the diverse fields of clinical diagnostics, high throughput drug screening and drug delivery systems.
Our Technologies
AmpliFlux Technology
Flow-through cell counting assay
Ultrasound-enhanced Particle Agglutination
Barbell Horn Ultrasonic Technology
Our company seeks to build strategic relationships with business partners that are interested in bringing our technologies to market.